The initial management of multiple myeloma in the era of novel agents: 2021 and beyond

被引：0
|
作者：
Nadeem, Omar [1 ]
Richardson, Paul G. [1 ]
机构：
[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Hematol Malignancies, Boston, MD USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷 / 02期
关键词：
OPEN-LABEL; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; COMBINATION; MULTICENTER; CARFILZOMIB; DARATUMUMAB; PHASE-2;
D O I：
10.1111/bjh.17407
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：213 / 215
页数：3
相关论文
共 50 条
  • [1] Multiple Myeloma in the Era of Novel Agents Introduction
    Dimopoulos, Meletios A.
    Attal, Michel
    SEMINARS IN HEMATOLOGY, 2009, 46 (02) : 107 - 109
  • [2] The impact of response kinetics following initial therapy for multiple myeloma in the era of novel agents
    Yan, Yuting
    Mao, Xuehan
    Liu Jiahui
    Fan Huishou
    Zengjun, Lizengjun
    Du, Chenxing
    Hao, Mu
    Qiu, Lugui
    An, Gang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E222 - +
  • [3] Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
    C S Chim
    S K Kumar
    R Z Orlowski
    G Cook
    P G Richardson
    M A Gertz
    S Giralt
    M V Mateos
    X Leleu
    K C Anderson
    Leukemia, 2018, 32 : 252 - 262
  • [4] Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
    Chim, C. S.
    Kumar, S. K.
    Orlowski, R. Z.
    Cook, G.
    Richardson, P. G.
    Gertz, M. A.
    Giralt, S.
    Mateos, M. V.
    Leleu, X.
    Anderson, K. C.
    LEUKEMIA, 2018, 32 (02) : 252 - 262
  • [5] Prognostic:: factors for multiple myeloma in the era of novel agents
    Blade, J.
    Rosinol, L.
    Cibeira, M. T.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 120
  • [6] Macrofocal multiple myeloma in the era of novel agents in China
    Dou, Xuelin
    Liu, Ruixia
    Liu, Yang
    Peng, Nan
    Wen, Lei
    Deng, Daoxing
    Cao, Leqing
    Li, Qian
    Wang, Liru
    Wang, Fengrong
    Mo, Xiaodong
    Lu, Jin
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2025, 16
  • [7] Maintenance therapy for multiple myeloma in the era of novel agents
    Facon, Thierry
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 279 - 285
  • [8] Extramedullary disease in multiple myeloma in the era of novel agents
    Blade, Joan
    Fernandez de Larrea, Carlos
    Rosinol, Laura
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (06) : 763 - 765
  • [9] The role of novel agents in the management of multiple myeloma
    Dimopoulos, M. A.
    Kastritis, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 267 - 267
  • [10] Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
    C. S. Chim
    S. K. Kumar
    R. Z. Orlowski
    G. Cook
    P. G. Richardson
    M. A. Gertz
    S. Giralt
    M. V. Mateos
    X. Leleu
    K. C. Anderson
    Leukemia, 2019, 33 : 1058 - 1059
12345